Radiopharmaceuticals for localization in target tissues exhibiting a regional pH shift relative to surrounding tissues

This patent relates to the preparation and use of radiopharmaceutical chemical compounds comprising a radioactive isotope, other than an isotope of iodine, in chemical combination with at least one primary, secondary or tertiary amino group. The compounds have a lipophilicity sufficiently high at a pH of 7.6 to permit passage of the compound from the blood of a mammal into a target organ or tissue and sufficiently low at a pH of 6.6 to prevent rapid return of the compound from the target organ or tissue to the blood. The compounds have a percent protein binding of less than ninety percent. These compounds may be selectively deposited in at least one target tissue or organ of a mammal, the tissue or organ of which has a significantly different intracellular pH than the blood of the mammal, by introducing the compound of the invention into the bloodstream of the mammal. A plurality of selenide compounds containing Se-75 isotope are claimed in relation to the patent. (U.K.)